Post-heparin lipolytic activity in diabetic patients with a history of mixed hyperlipemia. Relative rates against artificial substrates and human chylomicrons.
D000328:Adult; D002784:Cholesterol / Q000097:blood; D002914:Chylomicrons; D003059:Cocos; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000378:metabolism*; D005260:Female; D005989:Glycerides / Q000097:blood; D006493:Heparin / Q000494:pharmacology*; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000378:metabolism*; D008071:Lipoprotein Lipase / Q000378:metabolism*; D008074:Lipoproteins / Q000097:blood; D008297:Male; D008875:Middle Aged; D009821:Oils / Q000378:metabolism*; D013025:Glycine max
D002914:Chylomicrons; D005989:Glycerides; D008074:Lipoproteins; D009821:Oils; D006493:Heparin; D002784:Cholesterol; D008071:Lipoprotein Lipase